Literature DB >> 19326430

The MTHFR C677T and DeltaDNMT3B C-149T polymorphisms confer different risks for right- and left-sided colorectal cancer.

Barry Iacopetta1, Jane Heyworth, Jennifer Girschik, Fabienne Grieu, Cassandra Clayforth, Lin Fritschi.   

Abstract

Etiological risk factors for proximal (right-sided) colon cancers may be different to those of distal colon and rectal (left-sided) cancers if these tumors develop along distinct pathways. The CpG Island Methylator Phenotype (CIMP+) occurs in approximately 15% of colorectal cancers (CRC) and predominantly in the proximal colon. CIMP+ tumors have frequent methylation of gene promoter regions and increased tissue folate levels. The aim here was to determine whether polymorphisms in 2 genes involved in cellular methyl group metabolism were associated with different risks for right- and left-sided CRC. This population-based case-control study involved 859 incident cases of CRC and 973 sex and age-matched controls. Information on dietary folate and alcohol intake was obtained from food frequency questionnaires and information on the anatomical site of tumors from pathology reports. DNA was collected using FTA cards and genotyping performed for the MTHFR C677T and DeltaDNMT3B C-149T polymorphisms. The MTHFR 677 T allele was associated with increased risk for proximal colon cancer (adjusted odds ratio, AOR = 1.29) but decreased risk for distal cancers (AOR = 0.87). The increased risk for proximal cancers was especially pronounced in older individuals (AOR = 1.49) and those with a low folate diet (AOR = 1.67) or high alcohol consumption (AOR = 1.90). The DeltaDNMT3B-149 TT genotype was protective against proximal colon cancers (AOR = 0.65), but showed no association with the risk of distal colon and rectal cancers (AOR = 1.02). Epidemiological studies on dietary and genetic risk factors for CRC should take into account these may confer different risks for right- and left-sided tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19326430     DOI: 10.1002/ijc.24324

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  33 in total

1.  DNMT3B polymorphisms and cancer risk: a meta analysis of 24 case-control studies.

Authors:  Shimiao Zhu; Hui Zhang; Yang Tang; Peicai Liu; Jianmin Wang
Journal:  Mol Biol Rep       Date:  2011-09-22       Impact factor: 2.316

2.  MTHFR C677T polymorphism contributes to colorectal cancer susceptibility: evidence from 61 case-control studies.

Authors:  Xuewen Sheng; Yanxi Zhang; Erjiang Zhao; Su Lu; Xiaoli Zheng; Hong Ge; Weiquan Lu
Journal:  Mol Biol Rep       Date:  2012-06-23       Impact factor: 2.316

Review 3.  Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.

Authors:  Kaori Shima; Katsuhiko Nosho; Yoshifumi Baba; Mami Cantor; Jeffrey A Meyerhardt; Edward L Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Int J Cancer       Date:  2011-03-01       Impact factor: 7.396

4.  Genetic polymorphism of DNA methyltransferase 3B 149 C>T and risk of colorectal cancer: a meta-analysis.

Authors:  Qingkai Meng; Jingru Zhang; Bo Lian; Chun Song
Journal:  Tumour Biol       Date:  2013-11-01

Review 5.  Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis.

Authors:  Federica Zoratto; Luigi Rossi; Monica Verrico; Anselmo Papa; Enrico Basso; Angelo Zullo; Luigi Tomao; Adriana Romiti; Giuseppe Lo Russo; Silverio Tomao
Journal:  Tumour Biol       Date:  2014-03-28

6.  Folate and choline metabolism gene variants in relation to ovarian cancer risk in the Polish population.

Authors:  Piotr Pawlik; Adrianna Mostowska; Margarita Lianeri; Stefan Sajdak; Helena Kędzia; Paweł P Jagodzinski
Journal:  Mol Biol Rep       Date:  2011-12-20       Impact factor: 2.316

Review 7.  MicroRNA in rectal cancer.

Authors:  Azadeh Azizian; Jens Gruber; B Michael Ghadimi; Jochen Gaedcke
Journal:  World J Gastrointest Oncol       Date:  2016-05-15

8.  Genetic variability in the MTHFR gene and colorectal cancer risk using the colorectal cancer family registry.

Authors:  A Joan Levine; Jane C Figueiredo; Won Lee; Jenny N Poynter; David Conti; David J Duggan; Peter T Campbell; Polly Newcomb; Maria Elena Martinez; John L Hopper; Loic Le Marchand; John A Baron; Paul J Limburg; Cornelia M Ulrich; Robert W Haile
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

Review 9.  A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk.

Authors:  Muzeyyen Izmirli
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

10.  The 46359CT polymorphism of DNMT3B is associated with the risk of cervical cancer.

Authors:  Daniel Hernández-Sotelo; Rubén García-Aguilar; Yaneth Castro-Coronel; Jonathan J Magaña; Marco Antonio Leyva-Vazquez; Luz del Carmen Alarcón-Romero; Esther López-Bayghen; Berenice Illades-Aguiar
Journal:  Mol Biol Rep       Date:  2013-05-16       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.